Physician profile
Sarika Snell
NPI 1700106374
$12,624.02
in general payments reported to CMS, 2019-2025
40 companies · $2,862 in 2025
The $2,862 reported for 2025 was more than what 84% of Procedural Dermatology providers received nationally (typical 2025 total: $599).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,440 · 2020: $539 · 2021: $133 · 2022: $2,002 · 2023: $2,264 · 2024: $2,383 · 2025: $2,862.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,509.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,508.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,616.71 | 2019-2025 | |
| Pfizer INC. | $1,168.18 | 2019-2025 | |
| Galderma Laboratories, L.P. | $1,126.42 | 2019-2025 | Aklief, Oracea, Nemluvio |
| Genzyme Corporation | $784.91 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $704.94 | 2022-2025 | Sotyktu |
| Lilly USA, LLC | $650.91 | 2019-2025 | Taltz, Ebglyss, Olumiant |
| Novartis Pharmaceuticals Corporation | $645.21 | 2019-2025 | |
| Amgen INC. | $634.77 | 2020-2025 | Otezla, Otezla, Enbrel |
| Leo Pharma INC. | $622.14 | 2019-2025 | Adbry, Anzupgo, Spevigo |
| Regeneron Healthcare Solutions, INC. | $442.27 | 2019-2025 | Dupixent |
| Sun Pharmaceutical Industries INC. | $421.23 | 2019-2025 | Winlevi, Absorica Ld, Ilumya |
| Incyte Corporation | $386.96 | 2021-2025 | Opzelura |
| Janssen Biotech, INC. | $364.26 | 2019-2025 | Tremfya |
| Merz North America, INC. | $361.69 | 2022-2023 | Xeomin |
| Ucb, INC. | $330.42 | 2019-2025 | Bimzelx |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarika Snell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.